SciencewerkeDX
Latest News & Events
Year: 2022
EndoPredict is a second generation test – this means it is the newest type of test available for predicting breast cancer recurrence. Second generation tests combine your individual...
Should we use genetic signatures for chemotherapy decisions in ER+/HER2- premenopausal patients?
Join Myriad genetics at ESMO 2022 Industry Satellite Symposium...
Held on 12 July 2002 (Tuesday) from 3pm – 4pm, the webinar featured Prof. Peter J. Wild, Director of the Dr. Senckenberg Institute of Pathology
International Gynecologic Cancer Society (IGCS) Roundtable Webinar Held on 16 June 2022, the roundtable faculty discussed topics.
